Peripheral Mononuclear Cells Surface Markers Evaluation in Different Stages of Hepatocellular Carcinoma; in a Trial for Early and Accurate Diagnosis in Patients with Post-Hepatitis Liver Cirrhosis and Unremarkable Raised AFP

References

• Ganne-Carrié N, Nahon P. Hepatocellular carcinoma in the setting of alcohol-related liver disease. J Hepatol. 2019;70:284.
   PubMed Web of Science ®Google Scholar
• Mahmud N, Fricker Z, Hubbard RA, et al. Risk prediction models for post-operative mortality in patients with cirrhosis. Hepatology. 2021;73:204. doi:10.1002/hep.31558
   PubMed Web of Science ®Google Scholar
• Llovet JM, Villanueva A, Marrero JA, et al. Trial design and endpoints in hepatocellular carcinoma: AASLD consensus conference. Hepatology. 2021;73(Suppl 1):158. doi:10.1002/hep.31327
   PubMed Web of Science ®Google Scholar
• Kanwal F, Singal AG. Surveillance for hepatocellular carcinoma: current best practice and future direction. Gastroenterology. 2019;157:54. doi:10.1053/j.gastro.2019.02.049
   PubMed Web of Science ®Google Scholar
• Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380:1450.
   PubMed Web of Science ®Google Scholar
• Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 2010;11(10):889–896. PMID: 20856220. doi:10.1038/ni.1937
   PubMed Web of Science ®Google Scholar
• Morvan MG, Lanier LL. NK cells and cancer: you can teach innate cells new tricks. Nat Rev Cancer. 2016;16(1):7–19. PMID: 26694935. doi:10.1038/nrc.2015.5
   PubMed Web of Science ®Google Scholar
• Guillerey C, Smyth MJ. NK cells and cancer immunoediting. Curr Top Microbiol Immunol. 2016;395:115–145. PMID: 26025472. doi:10.1007/82_2015_446
   PubMed Web of Science ®Google Scholar
• Atkins D, Ross D, Kelley M. Acting in the face of uncertainty. Ann Intern Med. 2014;161:300.
   PubMed Web of Science ®Google Scholar
• Wolf E, Rich NE, Marrero JA, et al. Use of hepatocellular carcinoma surveillance in patients with cirrhosis: a systematic review and meta-analysis. Hepatology. 2021;73(2):713. doi:10.1002/hep.31309
   PubMed Web of Science ®Google Scholar
• Koteish A, Thuluvath PJ. Screening for hepatocellular carcinoma. J Vasc Interv Radiol. 2002;13(9 Pt 2):S185–S190. doi:10.1016/S1051-0443(07)61785-0
   PubMed Web of Science ®Google Scholar
• Borzio M, Borzio F, Macchi R, et al. The evaluation of fine-needle procedures for the diagnosis of focal liver lesions in cirrhosis. J Hepatol. 1994;20:117–121. doi:10.1016/S0168-8278(05)80477-5
   PubMed Web of Science ®Google Scholar
• Torzilli G, Belghiti J, Makuuchi M. Differences and similarities in the approach to hepatocellular carcinoma between Eastern and Western institutions. Liver Transpl. 2004;10(2 Suppl 1):S1–S2. doi:10.1002/lt.20032
   PubMedGoogle Scholar
• Bismuth H, Majno PE, Adam R. Liver transplantation for hepatocellular carcinoma. Semin Liver Dis. 1999;19:311–322. doi:10.1055/s-2007-1007120
   PubMed Web of Science ®Google Scholar
• Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358–380. doi:10.1002/hep.29086
   PubMed Web of Science ®Google Scholar
• Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg. 1964;1:1–85. doi:10.1016/S0011-3840(64)80003-4
   PubMedGoogle Scholar
• Kamarajah S, Frankel T, Sonnenday C, Cho C, Nathan H. Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): a Surveillance, Epidemiology, End Results (SEER) analysis. J Surg Oncol. 2017;117. doi:10.1002/jso.24908
   PubMed Web of Science ®Google Scholar
• Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19(3):329–338. doi:10.1055/s-2007-1007122
   PubMed Web of Science ®Google Scholar
• Hwang J, Kim SH, Lee MW, Lee JY. Small (≤ 2 cm) hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic 64-multirow detector CT. Br J Radiol. 2012;85(1015):e314–e322. doi:10.1259/bjr/27727228
   PubMed Web of Science ®Google Scholar
• Omata M, Lesmana LA, Tateishi R, et al. Asian Pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma. Hepatol Int. 2010;4:439–474. PMID:20827404. [PMC free article]. doi:10.1007/s12072-010-9165-7
   PubMed Web of Science ®Google Scholar
• Forner A, Vilana R, Ayuso C, et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology. 2008;47:97–104. PMID: 18069697. doi:10.1002/hep.21966
   PubMed Web of Science ®Google Scholar
• Fouts TR, Bagley K, Prado IJ, et al. Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection. Proc Natl Acad Sci U S A. 2015;112:E992–E999. doi:10.1073/pnas.1423669112
   PubMed Web of Science ®Google Scholar
• Uehata T, Iwasaki H, Vandenbon A, et al. Malt1-induced cleavage of regnase-1 in cd4(+) helper t cells regulates immune activation. Cell. 2013;153:1036–1049. doi:10.1016/j.cell.2013.04.034
   PubMed Web of Science ®Google Scholar
• Whiteside TL. Immune modulation of t-cell and nk (natural killer) cell activities by texs (tumour-derived exosomes). Biochem Soc Trans. 2013;41:245–251. doi:10.1042/BST20120265
   PubMed Web of Science ®Google Scholar
• Pearce EL, Poffenberger MC, Chang CH, Jones RG. Fueling immunity: insights into metabolism and lymphocyte function. Science. 2013;342:1242454. doi:10.1126/science.1242454
   PubMedGoogle Scholar
• Qin S, Ma S, Huang X, Lu D, Zhou Y, Jiang H. Th22 cells are associated with hepatocellular carcinoma development and progression. Chin J Cancer Res. 2014;26:135–141. doi:10.3978/j.issn.1000-9604.2014.02.14
   PubMed Web of Science ®Google Scholar
• Makarova-Rusher OV, Medina-Echeverz J, Duffy AG, Greten TF. The yin and yang of evasion and immune activation in HCC. J Hepatol. 2015;62:1420–1429. doi:10.1016/j.jhep.2015.02.038
   PubMed Web of Science ®Google Scholar
• Fujiwara Y, Shiba H, Furukawa K, et al. Perioperative change in white blood cell count predicts outcome of hepatic resection for hepatocellular carcinoma. J Hepatobiliary Pancreat Sci. 2010;17(6):892–897. PMID: 20449611. doi:10.1007/s00534-010-0290-4
   PubMed Web of Science ®Google Scholar
• Sajadieh A, Mouridsen MR, Selmer C, Intzilakis T, Nielsen OW, Haugaard SB. Monocyte number associated with incident cancer and mortality in middle-aged and elderly community-dwelling danes. Eur J Cancer. 2011;47(13):2015–2022. doi:10.1016/j.ejca.2011.02.015
   PubMed Web of Science ®Google Scholar
• Cros J, Cagnard N, Woollard K, et al. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity. 2010;33:375–386. doi:10.1016/j.immuni.2010.08.012
   PubMed Web of Science ®Google Scholar
• Cardoso CC, Matiollo C, Pereira CHJ, et al. Patterns of dendritic cell and monocyte subsets are associated with disease severity and mortality in liver cirrhosis patients. Sci Rep. 2021;11(1):5923. PMID: 33723292; PMCID: PMC7960697. doi:10.1038/s41598-021-85148-y
   PubMed Web of Science ®Google Scholar
• Hong YM, Yoon KT, Hwang TH, et al. Pretreatment peripheral neutrophils, lymphocytes and monocytes predict long-term survival in hepatocellular carcinoma. BMC Cancer. 2020;20:937. doi:10.1186/s12885-020-07105-8
   PubMed Web of Science ®Google Scholar
• Shen SL, Fu SJ, Huang XQ, et al. Elevated preoperative peripheral blood monocyte count predicts poor prognosis for hepatocellular carcinoma after curative resection. BMC Cancer. 2014;14:744. doi:10.1186/1471-2407-14-744
   PubMed Web of Science ®Google Scholar
• Jeon SH, Lee YJ, Kim HD, et al. Dynamic changes in peripheral blood monocytes early after anti-PD-1 therapy predict clinical outcomes in hepatocellular carcinoma. Cancer Immunol Immunother. 2022. doi:10.1007/s00262-022-03258-6
   PubMed Web of Science ®Google Scholar
• Buch AC, Patil A, Haldar N, et al. Relation of lymphocyte subsets and cytokines in different grades of alcoholic cirrhosis. J Clin Diagn Res. 2019;13(1):8–11. 4.
   Web of Science ®Google Scholar
• Wang F, Sun W, Xiao Q, et al. Peripheral T lymphocytes predict the severity and prognosis in patients with HBV-related acute-on-chronic liver failure. Medicine. 2021;100(5):e24075. doi:10.1097/MD.0000000000024075
   PubMed Web of Science ®Google Scholar
• Liu HZ, Deng W, Li JL, et al. Peripheral blood lymphocyte subset levels differ in patients with hepatocellular carcinoma. Oncotarget. 2016;7(47):77558–77564. PMID: 27813499; PMCID: PMC5363604. doi:10.18632/oncotarget.13041
   PubMedGoogle Scholar
• Buch A, Kulkarni RS, Kulkarni SS, Bhandari P. Journey of natural killer cells and their role in liver diseases. J Clin Diagn Res. 2022;16(4):EE01–EE05.
   Web of Science ®Google Scholar
• Heiberg IL, Pallett LJ, Winther TN, Hogh B, Maini MK, Peppa D. Defective natural killer cell anti-viral capacity in paediatric HBV infection. Clin Exp Immunol. 2015;179:466–476. doi:10.1111/cei.12470
   PubMed Web of Science ®Google Scholar
• Jun W, Lewis L. Natural killer cells and cancer. Adv Cancer Res. 2003;90:127–156.
   PubMed Web of Science ®Google Scholar
• Abumrad N, Storch J. Role of membrane and cytosolic fatty acid binding proteins in lipid processing by the small intestine. Chapter 66. In: Physiology of the Gastrointestinal Tract. Vol. 2. 4th ed. Elsevier Inc.; 2006:1693–1709.
   Google Scholar
• Alvin W. Martin, Diagnostic Immunohistochemistry. 3rd ed. Elsevier; 2011.
   Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–444. doi:10.1038/nature07205
   PubMed Web of Science ®Google Scholar
• Soucek L, Lawlor ER, Soto D, Shchors K, Swigart LB, Evan GI. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat Med. 2007;13:1211–1218. doi:10.1038/nm1649
   PubMed Web of Science ®Google Scholar
• Karin M. Nuclear factor-kappaB in cancer development and progression. Nature. 2006;441:431–436. doi:10.1038/nature04870
   PubMed Web of Science ®Google Scholar
• Liu M, Zhou J, Liu X, et al. Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma. Gut. 2020;69(2):365–379. PMID: 31076403. doi:10.1136/gutjnl-2018-317257
   PubMed Web of Science ®Google Scholar
• Mossanen JC, Tacke F. Role of lymphocytes in liver cancer. Oncoimmunology. 2013;2(11):e26468. PMID: 24498546; PMCID: PMC3906418. doi:10.4161/onci.26468
   PubMed Web of Science ®Google Scholar
• Sasaki A, Iwashita Y, Shibata K, Matsumoto T, Ohta M, Kitano S. Prognostic value of preoperative peripheral blood monocyte count in patients with hepatocellular carcinoma. Surgery. 2006;139(6):755–764.
   PubMed Web of Science ®Google Scholar
• Luo X, Zheng E, Wei L, et al. The fatty acid receptor CD36 promotes HCC progression through activating Src/PI3K/AKT axis-dependent aerobic glycolysis. Cell Death Dis. 2021;12(4):328. PMID: 33771982; PMCID: PMC7997878. doi:10.1038/s41419-021-03596-w
   PubMed Web of Science ®Google Scholar